---
title: "encorafenib"
slug: "encorafenib"
date: "2023-09-21"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Metastatic Colon Cancer]]

# encorafenib

- Colorectal Cancer
- ORAL
- 300 mg once daily; use in combination with cetuximab. [ref] Continue therapy until disease progression or unacceptable toxicity occurs. [ref]
- If concomitant use with moderate or strong inhibitors of CYP3A4 cannot be avoided, reduce dosage of encorafenib.

- [[BEACON]]
  - Kopetz S, Grothey A, Yaeger R, et al. Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. N Engl J Med. 2019;381(17):1632-1643.
